Helium Health
-65%
est. 2Y upside i
Africa's #1 healthcare technology provider.
Rank
#1986
Sector
HealthTech
Est. Liquidity
~3Y
Data Quality
Data: MediumHelium Health operates in a rapidly expanding African HealthTech market (projected to grow >23% YoY to $7.59B by 2029), offering a comprehensive suite of EMR, telemedicine, and financing solutions.
Last updated: March 10, 2026
Helium Health successfully expands its integrated EMR, telemedicine, and financing solutions across key African markets, leveraging new AI tools like CareCopilot and HeliumDoc AI to drive adoption. Revenue grows to over $80M by 2028, justifying a $550M+ valuation at 6.8x revenue, as the company becomes a dominant regional player and an attractive acquisition target for a global healthtech firm.
Helium Health maintains its strong position in Nigeria and achieves moderate expansion into other West African markets, growing revenue at its projected 23% YoY. It continues to face competition and regulatory hurdles but successfully scales HeliumCredit. Revenue reaches approximately $56M by 2028, leading to a valuation of around $385M, providing a meaningful return for common shareholders.
Increased competition from local players offering offline solutions and more flexible pricing, coupled with persistent regulatory fragmentation and infrastructure challenges, slows Helium Health's growth significantly. Revenue stalls below $40M, and a down round to $88M valuation wipes out most common-stock value due to the $42M in liquidation preferences.
Preference Stack Risk
highInvestors hold $42M in liquidation preferences ahead of common stock, on an estimated current valuation of $220M.
Dilution Risk
moderateAs a Series B company, at least one more significant funding round (Series C) is likely before an exit, which will cause further dilution.
Secondary Liquidity
limitedNo active secondary market or tender offers are publicly noted for Helium Health at this stage.
Questions to Ask at the Interview
Strategic questions based on Helium Health's data — designed to show you've done your homework.
- 1
“Given the challenges of internet dependency and SaaS pricing in some African markets, how is Helium Health adapting its product and business model to ensure broader accessibility and adoption, especially against competitors offering offline solutions?”
- 2
“With the African digital health market projected for significant growth, what are Helium Health's specific plans for geographic expansion beyond Nigeria and how will it navigate the diverse regulatory landscapes across the continent?”
- 3
“Considering the $42M in total funding and the Series B stage, what is the company's anticipated timeline for a liquidity event (IPO or acquisition), and how is management thinking about managing dilution for common shareholders in future funding rounds?”
Community
Valuation Sentiment
Our model estimates -65% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.